Does antiaggregant administration lead to early diagnosis in proximal colon cancer?

INTRODUCTION[|]Cancers of the proximal colon are often diagnosed in advanced stages with iron deficiency anaemia and nonspecific symptoms. Aspirin and clopidogrel are commonly used antiaggregant agents for various clinical conditions. The aim of this study was to investigate the effects of antiaggre...

Full description

Bibliographic Details
Main Authors: Ulaş Aday, Ebubekir Gündeş, Hüseyin Çiyiltepe, Durmuş Ali Çetin, Kamuran Cumhur Değer, Selçuk Gülmez, Aziz Serkan Senger, Emre Bozdağ
Format: Article
Language:English
Published: KARE Publishing 2017-08-01
Series:İstanbul Kuzey Klinikleri
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-80148
_version_ 1828023802735362048
author Ulaş Aday
Ebubekir Gündeş
Hüseyin Çiyiltepe
Durmuş Ali Çetin
Kamuran Cumhur Değer
Selçuk Gülmez
Aziz Serkan Senger
Emre Bozdağ
author_facet Ulaş Aday
Ebubekir Gündeş
Hüseyin Çiyiltepe
Durmuş Ali Çetin
Kamuran Cumhur Değer
Selçuk Gülmez
Aziz Serkan Senger
Emre Bozdağ
author_sort Ulaş Aday
collection DOAJ
description INTRODUCTION[|]Cancers of the proximal colon are often diagnosed in advanced stages with iron deficiency anaemia and nonspecific symptoms. Aspirin and clopidogrel are commonly used antiaggregant agents for various clinical conditions. The aim of this study was to investigate the effects of antiaggregant medication on the early diagnosis of proximal colon cancer.[¤]METHODS[|]We retrospectively reviewed the cases of colon cancer patients who had received curative surgical procedures in our clinic between 1 January 2013 and 31 July 2016. The clinical and pathological results of patients who had used antiaggregant drugs were compared to those who had not.[¤]RESULTS[|]During the studied period, 246 colorectal cancer patients underwent curative surgical procedures. Of the 67 patients with proximal colon cancer who were included in the study, 27 (40.3%) were on antiaggregant medication. The mean age of the antiaggregant group was 67.1 year (34–88 years), while it was 58.3 (34–83 years) for the non-antiaggregant group; the difference between the two was statistically significant (p = 0.03). A pathological evaluation revealed that 74.1% of the antiaggregant group were in the early stages (Stage I/II: 7/13), while 42.5% of the non-antiaggregant group were in the early stages (Stage I–II: 2/15); the difference was statistically significant (p=0.011).[¤]DISCUSSION AND CONCLUSION[|]Antiaggregant medication has a positive effect on diagnosing proximal colon cancer at early-stages. Patients using aspirin or clopidogrel should undergo a complete colonoscopic evaluation in the presence of gastrointestinal tract bleeding or newly developed anaemia.[¤]
first_indexed 2024-04-10T12:34:34Z
format Article
id doaj.art-d7e4bc1e43744ae7b4f4b9020f0a3c7b
institution Directory Open Access Journal
issn 2148-4902
language English
last_indexed 2024-04-10T12:34:34Z
publishDate 2017-08-01
publisher KARE Publishing
record_format Article
series İstanbul Kuzey Klinikleri
spelling doaj.art-d7e4bc1e43744ae7b4f4b9020f0a3c7b2023-02-15T16:14:44ZengKARE Publishingİstanbul Kuzey Klinikleri2148-49022017-08-014217317910.14744/nci.2017.80148NCI-80148Does antiaggregant administration lead to early diagnosis in proximal colon cancer?Ulaş Aday0Ebubekir Gündeş1Hüseyin Çiyiltepe2Durmuş Ali Çetin3Kamuran Cumhur Değer4Selçuk Gülmez5Aziz Serkan Senger6Emre Bozdağ7Kosuyolu High Speciality Education and Training Hospital, Gastroenterology Surgery,Kartal,İstanbul,TurkeyKosuyolu High Speciality Education and Training Hospital, Gastroenterology Surgery,Kartal,İstanbul,TurkeyKosuyolu High Speciality Education and Training Hospital, Gastroenterology Surgery,Kartal,İstanbul,TurkeyKosuyolu High Speciality Education and Training Hospital, Gastroenterology Surgery,Kartal,İstanbul,TurkeyKosuyolu High Speciality Education and Training Hospital, Gastroenterology Surgery,Kartal,İstanbul,TurkeyKosuyolu High Speciality Education and Training Hospital, Gastroenterology Surgery,Kartal,İstanbul,TurkeyKosuyolu High Speciality Education and Training Hospital, Gastroenterology Surgery,Kartal,İstanbul,TurkeyKosuyolu High Speciality Education and Training Hospital, Gastroenterology Surgery,Kartal,İstanbul,TurkeyINTRODUCTION[|]Cancers of the proximal colon are often diagnosed in advanced stages with iron deficiency anaemia and nonspecific symptoms. Aspirin and clopidogrel are commonly used antiaggregant agents for various clinical conditions. The aim of this study was to investigate the effects of antiaggregant medication on the early diagnosis of proximal colon cancer.[¤]METHODS[|]We retrospectively reviewed the cases of colon cancer patients who had received curative surgical procedures in our clinic between 1 January 2013 and 31 July 2016. The clinical and pathological results of patients who had used antiaggregant drugs were compared to those who had not.[¤]RESULTS[|]During the studied period, 246 colorectal cancer patients underwent curative surgical procedures. Of the 67 patients with proximal colon cancer who were included in the study, 27 (40.3%) were on antiaggregant medication. The mean age of the antiaggregant group was 67.1 year (34–88 years), while it was 58.3 (34–83 years) for the non-antiaggregant group; the difference between the two was statistically significant (p = 0.03). A pathological evaluation revealed that 74.1% of the antiaggregant group were in the early stages (Stage I/II: 7/13), while 42.5% of the non-antiaggregant group were in the early stages (Stage I–II: 2/15); the difference was statistically significant (p=0.011).[¤]DISCUSSION AND CONCLUSION[|]Antiaggregant medication has a positive effect on diagnosing proximal colon cancer at early-stages. Patients using aspirin or clopidogrel should undergo a complete colonoscopic evaluation in the presence of gastrointestinal tract bleeding or newly developed anaemia.[¤]https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-80148antiaggregant medicationproximal colon cancerearly-stage
spellingShingle Ulaş Aday
Ebubekir Gündeş
Hüseyin Çiyiltepe
Durmuş Ali Çetin
Kamuran Cumhur Değer
Selçuk Gülmez
Aziz Serkan Senger
Emre Bozdağ
Does antiaggregant administration lead to early diagnosis in proximal colon cancer?
İstanbul Kuzey Klinikleri
antiaggregant medication
proximal colon cancer
early-stage
title Does antiaggregant administration lead to early diagnosis in proximal colon cancer?
title_full Does antiaggregant administration lead to early diagnosis in proximal colon cancer?
title_fullStr Does antiaggregant administration lead to early diagnosis in proximal colon cancer?
title_full_unstemmed Does antiaggregant administration lead to early diagnosis in proximal colon cancer?
title_short Does antiaggregant administration lead to early diagnosis in proximal colon cancer?
title_sort does antiaggregant administration lead to early diagnosis in proximal colon cancer
topic antiaggregant medication
proximal colon cancer
early-stage
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-80148
work_keys_str_mv AT ulasaday doesantiaggregantadministrationleadtoearlydiagnosisinproximalcoloncancer
AT ebubekirgundes doesantiaggregantadministrationleadtoearlydiagnosisinproximalcoloncancer
AT huseyinciyiltepe doesantiaggregantadministrationleadtoearlydiagnosisinproximalcoloncancer
AT durmusalicetin doesantiaggregantadministrationleadtoearlydiagnosisinproximalcoloncancer
AT kamurancumhurdeger doesantiaggregantadministrationleadtoearlydiagnosisinproximalcoloncancer
AT selcukgulmez doesantiaggregantadministrationleadtoearlydiagnosisinproximalcoloncancer
AT azizserkansenger doesantiaggregantadministrationleadtoearlydiagnosisinproximalcoloncancer
AT emrebozdag doesantiaggregantadministrationleadtoearlydiagnosisinproximalcoloncancer